Pasar al contenido principal

BIOLOGIA Y MEDICINA REDOX

RED2018-102576-T

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Redes Investigación /Redes Excelencia
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Mitochondrial dynamics maintain muscle stem cell regenerative competence throughout adult life by regulating metabolism and mitophagy

  • Hong, Xiaotong
  • Isern, Joan
  • Campanario, Silvia
  • Perdiguero, Eusebio, 1968-
  • Ramírez Pardo, Ignacio
  • Segalés Dalmau, Jessica
  • Hernansanz-Agustín, Pablo
  • Curtabbi, Andrea
  • Deryagin, Oleg
  • Pollán, Angela
  • González-Reyes, José A.
  • Villalba, José M.
  • Sandri, Marco
  • Serrano Sánchez, Antonio L.
  • Enríquez, José Antonio
  • Muñoz Cánoves, Pura, 1962-
Skeletal muscle regeneration depends on the correct expansion of resident quiescent stem cells (satellite cells), a process that becomes less efficient with aging. Here, we show that mitochondrial dynamics are essential for the successful regenerative capacity of satellite cells. The loss of mitochondrial fission in satellite cells-due to aging or genetic impairment-deregulates the mitochondrial electron transport chain (ETC), leading to inefficient oxidative phosphorylation (OXPHOS) metabolism and mitophagy and increased oxidative stress. This state results in muscle regenerative failure, which is caused by the reduced proliferation and functional loss of satellite cells. Regenerative functions can be restored in fission-impaired or aged satellite cells by the re-establishment of mitochondrial dynamics (by activating fission or preventing fusion), OXPHOS, or mitophagy. Thus, mitochondrial shape and physical networking controls stem cell regenerative functions by regulating metabolism and proteostasis. As mitochondrial fission occurs less frequently in the satellite cells in older humans, our findings have implications for regeneration therapies in sarcopenia., Work in the PMC laboratory was supported by Spanish Ministerio de Ciencia e Innovación ( RTI2018-096068 to P.M.-C. and E.P), ERC - 2016-AdG-741966 , LaCaixa - HEALTH-HR17-00040 , MDA , UPGRADE-H2020-825825 , AFM-Telethon , DPP-Spain , Fundació La Marató TV3-80/19-202021 to P.M.-C; Fundació La Marató TV3-137/38-202033 to A.L.S.; partly supported by Milky Way Research Foundation (MWRF) to P.M.-C; Severo Ochoa Program for Centers of Excellence to CNIC ( SEV-2015-0505 ) and Maria de Maeztu Program for Units of Excellence to UPF ( MDM-2014-0370 ). Work in the JAE laboratory was supported by Ministerio de Ciencia e Innovacion ( RTI2018-099357-B-I00 , RED2018-102576-T ), Human Frontier Science Program HFSP ( RGP0016/2018 ), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimento Saludable ( CIBERFES16/10/00282 ), and Leduq Foundation award ( REDOX-17CVD04 ). Work in JMV laboratory was supported by the Spanish Ministerio de Ciencia e Innovación ( RTI2018-100695-B-I00 ), Spanish Junta de Andalucía ( P18-RT-4264 , 1263735-R and BIO-276 ), the FEDER Funding Program from the European Union , and Universidad de Córdoba . The authors are indebted to the personnel from the Servicio Centralizado de Apoyo a la Investigación (SCAI; University of Córdoba) for technical support with the transmission electron microscope. Work in MS laboratory was funded by the Italian Assoc. for Cancer Research ( AIRC IG-D17388 and ID23257 ) and ASI (MARS-PRE, project DC-VUM-2017-006). X.H., S.C., I.R.-P, and A.C were supported by Severo Ochoa PFI , PI , FPI , and H2020 Marie Skłodowska-Curie Actions predoctoral fellowships, respectively. P.H.-A was supported by Juan de la Cierva-Incorporación fellowship.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus

  • Borrás, Consuelo
  • Abdelaziz, Kheira M.
  • Díaz, Ana
  • Gambini,Juan
  • Jové Font, Mariona
  • López-Grueso, Raul
  • Mas-Bargues, Cristina
  • Monleón, Daniel
  • Pamplona Gras, Reinald
  • Viña Ribes, José
Soya consumption can decrease oxidative stress in animal models. Moreover, phytoestrogens such as genistein, present in soya, can mimic some of the beneficial effects of estrogens and are devoid of significant side effects, such as cancer. In this study, we have performed a controlled lifelong study with male OF1 mice that consumed either a soya-free diet or a soya-rich diet. We show that, although we found an increase in the expression and activity of antioxidant enzymes in soya-consuming mice, it did not increase lifespan. We reasoned that the soya diet could not increase lifespan in a very healthy population, but perhaps it could extend health span in stressed animals such as type 2 diabetic Goto Kakizaki (GK) rats. Indeed, this was the case: we found that male GK rats consuming a soya-rich diet developed the disease at a lower rate and, therefore, lived longer than soya-free dietconsuming rats., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RBI00/AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería, de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N◦ 696295 of the EU Horizon 2020 Research and Innovation Programme) to J.V. and PID2020-113839RB-I00 of the Ministry of Science and Innovation, PCIN-2017-117 of the Ministry of Economy and Competitiveness, the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to C.B. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glucose metabolism links astroglial mitochondria to cannabinoid effects

  • Jimenez-Blasco, Daniel
  • Busquets-Garcia, Arnau
  • Hebert-Chatelain, Etienne
  • Serrat, Roman
  • Vicente-Gutiérrez, Carlos
  • Ioannidou, Christina
  • Gómez-Sotres, Paula
  • López-Fabuel, Irene
  • Resch-Beusher, Monica
  • Resel, Eva
  • Arnouil, Dorian
  • Saraswat, Dave
  • Varilh, Marjorie
  • Cannich, Astrid
  • Julio-Kalajzic, Francisca
  • Bonilla-Del Río, Itziar
  • Almeida, Angeles
  • Puente, Nagore
  • Achicallende, Svein
  • López-Rodríguez, María L.
  • Jollé, Charlotte
  • Déglon, Nicole
  • Pellerin, Luc
  • Josephine, Charlene
  • Bonvento, Gilles
  • Panatier, Aude
  • Lutz, Beat
  • Piazza, Pier Vincenzo
  • Guzmán, Manuel
  • Bellocchio, Luigi
  • Bouzier-Sore, Anne-Karine
  • Grandes, Pedro
  • Bolaños, Juan P.
  • Marsicano, Giovanni
Astrocytes take up glucose from the bloodstream to provide energy to the brain, thereby allowing neuronal activity and behavioural responses1,2,3,4,5. By contrast, astrocytes are under neuronal control through specific neurotransmitter receptors5,6,7. However, whether the activation of astroglial receptors can directly regulate cellular glucose metabolism to eventually modulate behavioural responses is unclear. Here we show that activation of mouse astroglial type-1 cannabinoid receptors associated with mitochondrial membranes (mtCB1) hampers the metabolism of glucose and the production of lactate in the brain, resulting in altered neuronal functions and, in turn, impaired behavioural responses in social interaction assays. Specifically, activation of astroglial mtCB1 receptors reduces the phosphorylation of the mitochondrial complex I subunit NDUFS4, which decreases the stability and activity of complex I. This leads to a reduction in the generation of reactive oxygen species by astrocytes and affects the glycolytic production of lactate through the hypoxia-inducible factor 1 pathway, eventually resulting in neuronal redox stress and impairment of behavioural responses in social interaction assays. Genetic and pharmacological correction of each of these effects abolishes the effect of cannabinoid treatment on the observed behaviour. These findings suggest that mtCB1 receptor signalling can directly regulate astroglial glucose metabolism to fine-tune neuronal activity and behaviour in mice., This work was funded by: INSERM, the European Research Council (Endofood, ERC–2010–StG–260515 and CannaPreg, ERC-2014-PoC-640923, MiCaBra, ERC-2017-AdG-786467), Fondation pour la Recherche Medicale (FRM, DRM20101220445), the Human Frontiers Science Program, Region Nouvelle Aquitaine and Agence Nationale de la Recherche (ANR; NeuroNutriSens ANR-13-BSV4-0006, CaCoVi ANR 18-CE16-0001-02, MitObesity ANR 18-CE14-0029-01, ORUPS ANR-16-CE37-0010-01 and BRAIN ANR-10-LABX-0043) (to G.M.); NIH/NIDA (1R21DA037678-01), Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2016-78114-R and RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), an EU BATCure grant (666918), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces (to J.P.B.); Instituto de Salud Carlos III (PI18/00285; RD16/0019/0018), the European Regional Development Fund, the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009), Junta de Castilla y León (IES007P17) and Fundación Ramón Areces to (A.A.); French State/ANR/IdEx (ANR-10-IDEX-03-02), Eu-Fp7 (FP7-PEOPLE-2013-IEF-623638) and Ramon y Cajal Investigator Program (RYC-2017-21776) (to A.B.-G.); FRM (SPF20121226369) (to R.S.); FRM (ARF20140129235) (to L.B.); Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2015-64945-R and RTI2018-095311-B-I00) (to M.G.); Canada Research Chair, Alzheimer Society of Canada—Brain Canada (17-09), Natural Sciences and Engineering Research Council (RGPIN-2015-05880), Canadian Breast Cancer Foundation (2015-317342), Canadian Health Research Institute (CIHR, 388808), New Brunswick Innovation Foundation, New Brunswick Health Research Foundation and Université de Moncton (to E.H.-C.); Basque Government (IT1230-19), Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III), European Regional Development Funds-European Union (ERDF-EU; RD16/0017/0012) and MINECO/FEDER, UE (SAF2015-65034-R) (to P.G.); University of the Basque Country PhD contract (PIF 16/251) (to S.A.); POP contract (BES-2016-076766, BES-C-2016-0051) (to I.B.-D.R.); French State/ANR (ANR-10-IDEX and TRAIL ANR-10-LABX-57); French-Swiss ANR-FNS (ANR-15- CE37-0012) (to A.-K.B.-S.); SFB/TRR 58 ‘Fear, anxiety, anxiety disorders’ (subproject A04); and CRC 1193 ‘Neurobiology of resilience’ (subproject B04) (to B.L.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

l-Serine links metabolism with neurotransmission

  • Maugard, Marianne
  • Vigneron, Pierre-Antoine
  • Bolaños, Juan P.
  • Bonvento, Gilles
Brain energy metabolism is often considered as a succession of biochemical steps that metabolize the fuel (glucose and oxygen) for the unique purpose of providing sufficient ATP to maintain the huge information processing power of the brain. However, a significant fraction (10–15 %) of glucose is shunted away from the ATP-producing pathway (oxidative phosphorylation) and may be used to support other functions. Recent studies have pointed to the marked compartmentation of energy metabolic pathways between neurons and glial cells. Here, we focused our attention on the biosynthesis of l-serine, a non-essential amino acid that is formed exclusively in glial cells (mostly astrocytes) by re-routing the metabolic fate of the glycolytic intermediate, 3-phosphoglycerate (3PG). This metabolic pathway is called the phosphorylated pathway and transforms 3PG into l-serine via three enzymatic reactions. We first compiled the available data on the mechanisms that regulate the flux through this metabolic pathway. We then reviewed the current evidence that is beginning to unravel the roles of l-serine both in the healthy and diseased brain, leading to the notion that this specific metabolic pathway connects glial metabolism with synaptic activity and plasticity. We finally suggest that restoring astrocyte-mediated l-serine homeostasis may provide new therapeutic strategies for brain disorders., This work was supported by grants from the Agence Nationale de la Recherche (ANR 2011MALZ-0003 to GB), Association France Alzheimer and Fondation de France (Prix Spécial 2012 to GB), Fondation Plan Alzheimer (GB), Infrastructure de Recherche translationnelle pour les Biothérapies en Neurosciences-NeurATRIS ANR-11-INBS-0011 (GB). PAV is a recipient of a PhD fellowship from the Fondation pour la Recherche Médicale (FRM grant number ECO20170637547). Juan P. Bolanos is funded by MCINU (PID2019-105699RB-I00/ AEI / 10.13039/501100011033 and RED2018-102576-T), Instituto de Salud Carlos III (RD12/0043/0021), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, and Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nuclear factor kappa B signaling complexes in acute inflammation

  • Rius-Pérez, Sergio
  • Pérez, Salvador
  • Martí-Andrés, Pablo
  • Monsalve, María
  • Sastre, Juan
[Significance]: Nuclear factor kappa B (NF-κB) is a master regulator of the inflammatory response and represents a key regulatory node in the complex inflammatory signaling network. In addition, selective NF-κB transcriptional activity on specific target genes occurs through the control of redox-sensitive NF-κB interactions., [Recent Advances]: The selective NF-κB response is mediated by redox-modulated NF-κB complexes with ribosomal protein S3 (RPS3), Pirin (PIR). cAMP response element-binding (CREB)-binding protein (CBP)/p300, peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), activator protein-1 (AP-1), signal transducer and activator of transcription 3 (STAT3), early growth response protein 1 (EGR-1), and SP-1. NF-κB is cooperatively coactivated with AP-1, STAT3, EGR-1, and SP-1 during the inflammatory process, whereas NF-κB complexes with CBP/p300 and PGC-1α regulate the expression of antioxidant genes. PGC-1α may act as selective repressor of phospho-p65 toward interleukin-6 (IL-6) in acute inflammation. p65 and nuclear factor erythroid 2-related factor 2 (NRF2) compete for binding to coactivator CBP/p300 playing opposite roles in the regulation of inflammatory genes. S-nitrosylation or tyrosine nitration favors the recruitment of specific NF-κB subunits to κB sites., [Critical Issues]: NF-κB is a redox-sensitive transcription factor that forms specific signaling complexes to regulate selectively the expression of target genes in acute inflammation. Protein–protein interactions with coregulatory proteins, other transcription factors, and chromatin-remodeling proteins provide transcriptional specificity to NF-κB. Furthermore, different NF-κB subunits may form distinct redox-sensitive homo- and heterodimers with distinct affinities for κB sites., [Future Directions]: Further research is required to elucidate the whole NF-κB interactome to fully characterize the complex NF-κB signaling network in redox signaling, inflammation, and cancer., This work was supported by Grant SAF2015–71208-R with FEDER funds from Spanish Ministry of Economy and Competitiveness to J.S. and by network RED2018-102576-T from the Spanish Ministry of Science, Innovation and Universities to J.S. and M.M.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity

  • Acín-Pérez, Rebeca
  • Iborra, Salvador
  • Martí-Mateos, Yolanda
  • Cook, Emma C. L.
  • Conde-Garrosa, Ruth
  • Petcherski, Anton
  • Muñoz, María del Mar
  • Martínez de Mena, Raquel
  • Krishnan, Karthickeyan Chella
  • Jiménez, Concepción
  • Bolaños, Juan P.
  • Laakso, Markku
  • Lusis, Aldons J.
  • Shirihai, Orian S.
  • Sancho, David
  • Enríquez, José Antonio
Proinflammatory macrophages are key in the development of obesity. In addition, reactive oxygen species (ROS), which activate the Fgr tyrosine kinase, also contribute to obesity. Here we show that ablation of Fgr impairs proinflammatory macrophage polarization while preventing high-fat diet (HFD)-induced obesity in mice. Systemic ablation of Fgr increases lipolysis and liver fatty acid oxidation, thereby avoiding steatosis. Knockout of Fgr in bone marrow (BM)-derived cells is sufficient to protect against insulin resistance and liver steatosis following HFD feeding, while the transfer of Fgr-expressing BM-derived cells reverts protection from HFD feeding in Fgr-deficient hosts. Scavenging of mitochondrial peroxides is sufficient to prevent Fgr activation in BM-derived cells and HFD-induced obesity. Moreover, Fgr expression is higher in proinflammatory macrophages and correlates with obesity traits in both mice and humans. Thus, our findings reveal the mitochondrial ROS–Fgr kinase as a key regulatory axis in proinflammatory adipose tissue macrophage activation, diet-induced obesity, insulin resistance and liver steatosis., The METSIM study was supported by grants from the Academy of Finland (no. 321428), Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular Research, Centre of Excellence of Cardiovascular and Metabolic Diseases and the Academy of Finland (to M.L.). Work in the laboratory of J.A.E. is funded by the CNIC and a grant by Ministerio de Ciencia, Innovación e Universidades (MICINN), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER; SAF2015-65633-R and RTI2018-099357-B-I00), the EU (UE0/MCA317433), the Biomedical Research Networking Center on Frailty and Healthy Ageing (CIBERFES-ISCiii) and the HFSP agency (RGP0016/2018). Work in the laboratory of D.S. is funded by the CNIC; the European Research Council (ERC-2016-Consolidator Grant 725091); the European Commission (635122-PROCROP H2020); MICINN, AEI and FEDER (SAF2016-79040-R and PID2019-108157RB); Comunidad de Madrid (B2017/BMD-3733 Immunothercan-CM); FIS-Instituto de Salud Carlos III, MICINN and FEDER (RD16/0015/0018-REEM); the Acteria Foundation; Atresmedia (Constantes y Vitales prize); and Fundació La Marató de TV3 (201723). Work in the laboratory of O.S.S. is funded by National Institutes of Health (NIH; R01 DK099618-05, R01 CA232056-01, R21AG060456-01 and R21 AG063373-01) and the American Diabetes Association (1-19-IBS-049). Work in laboratory of A.J.L. was supported by NIH-PO1HL028481 and NIH-R01DK117850 (A.J.L.). Work in the laboratory of M.L. was funded by the Academy of Finland. Work in the laboratory of J.P.B. was funded by Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2016-78114-R and RED2018‐102576‐T), Instituto de Salud Carlos III (CB16/10/00282), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), MICINN and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505). K.C.K. is funded by NIH-K99 DK120875 and AHA Fellowship 18POST33990256. S.I. is funded by RYC-2016-19463 and RTI2018-094484-B-I00.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke

  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Sobrino, Tomás
  • Castillo, José
  • Bolaños, Juan P.
  • Almeida, Angeles
Failure of neurons to efficiently repair DNA double-strand breaks (DSBs) contributes to cerebral damage after stroke. However, the molecular machinery that regulates DNA repair in this neurological disorder is unknown. Here, we found that DSBs in oxygen/glucose-deprived (OGD) neurons spatiotemporally correlated with the up-regulation of WRAP53 (WD40-encoding p53-antisense RNA), which translocated to the nucleus to activate the DSB repair response. Mechanistically, OGD triggered a burst in reactive oxygen species that induced both DSBs and translocation of WRAP53 to the nucleus to promote DNA repair, a pathway that was confirmed in an in vivo mouse model of stroke. Noticeably, nuclear translocation of WRAP53 occurred faster in OGD neurons expressing the Wrap53 human nonsynonymous single-nucleotide polymorphism (SNP) rs2287499 (c.202C>G). Patients carrying this SNP showed less infarct volume and better functional outcome after stroke. These results indicate that WRAP53 fosters DNA repair and neuronal survival to promote functional recovery after stroke., This work was funded by the Instituto de Salud Carlos III (PI18/00265 and RD16/0019/0018 to A.A., RD16/0019/0001 to J.C., and CPII17/00027 to T.S.), European Regional Development Fund (FEDER) to Ministerio de Ciencia en Innovación (SAF2016-78114-R and RED2018-102576-T to J.P.B. and SAF2017-90794-REDT to A.A.), CIBERFES (CB16/10/00282 to J.P.B.), European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009 to A.A.), Junta de Castilla y León (IES007P17 to A.A. and Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León to A.A. and J.P.B.), Fundación Ramón Areces (to A.A. and J.P.B.), and Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer

  • González-Cámpora, Raúl
  • Rodríguez-Hernández, María A.
  • Negrete, María
  • Ranguelova, Kalina
  • Rossin, Aurelie
  • Choya-Foces, Carmen
  • Cruz, Patricia de la
  • Miranda-Vizuete, Antonio
  • Martínez-Ruiz, Antonio
  • Rius-Pérez, Sergio
  • Sastre, Juan
  • Bárcena, José Antonio
  • Hueber, Anne-Odile
  • Padilla, Alicia C.
  • Muntané, Jordi
Hepatocellular carcinoma (HCC) represents 80% of the primary hepatic neoplasms. It is the sixth most frequent neoplasm, the fourth cause of cancer-related death, and 7% of registered malignancies. Sorafenib is the first line molecular targeted therapy for patients in advanced stage of HCC. The present study shows that Sorafenib exerts free radical scavenging properties associated with the downregulation of nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression in liver cancer cells. The experimental downregulation and/or overexpression strategies showed that Trx1 induced activation of nitric oxide synthase (NOS) type 3 (NOS3) and S-nitrosation (SNO) of CD95 receptor leading to an increase of caspase-8 activity and cell proliferation, as well as reduction of caspase-3 activity in liver cancer cells. In addition, Sorafenib transiently increased mRNA expression and activity of S-nitrosoglutathione reductase (GSNOR) in HepG2 cells. Different experimental models of hepatocarcinogenesis based on the subcutaneous implantation of HepG2 cells in nude mice, as well as the induction of HCC by diethylnitrosamine (DEN) confirmed the relevance of Trx1 downregulation during the proapoptotic and antiproliferative properties induced by Sorafenib. In conclusion, the induction of apoptosis and antiproliferative properties by Sorafenib were related to Trx1 downregulation that appeared to play a relevant role on SNO of NOS3 and CD95 in HepG2 cells. The transient increase of GSNOR might also participate in the deactivation of CD95-dependent proliferative signaling in liver cancer cells., This study was funded by Institute of Health Carlos III (ISCIII) (PI13/00021, PI15/00107, PI16/00090 and PI19/01266), Spanish Ministry of Economy and Competitiveness (SAF2015-71208-R, BFU2016-8006-P, PGC2018-094276-B-I00 and RED2018-102576-T), Andalusian Ministry of Economy, Innovation, Science and Employment (BIO-216 and CTS-6264) and Andalusian Ministry of Equality, Health and Social Policies (PI-00025-2013 and PI-0198-2016). P de la C–O was supported by FPU predoctoral fellowship (FPU17/00026) from Ministry of Education, Culture and Sports. We thank the Biomedical Research Network Center for Cardiovascular Diseases (CIBERCV), and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd) founded by the ISCIII and co-financed by European Development Regional Fund “A way to achieve Europe” ERDF for their financial support.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cellular models for primary coq deficiency pathogenesis study

  • Santos-Ocaña, Carlos
  • Cascajo Almenara, M. V.
  • Alcázar-Fabra, María
  • Staiano, Carmine
  • López-Lluch, Guillermo
  • Brea-Calvo, Gloria
  • Navas, Plácido
© 2021 by the authors., Primary coenzyme Q10 (CoQ) deficiency includes a heterogeneous group of mitochondrial diseases characterized by low mitochondrial levels of CoQ due to decreased endogenous biosynthesis rate. These diseases respond to CoQ treatment mainly at the early stages of the disease. The advances in the next generation sequencing (NGS) as whole-exome sequencing (WES) and whole-genome sequencing (WGS) have increased the discoveries of mutations in either gene already described to participate in CoQ biosynthesis or new genes also involved in this pathway. However, these technologies usually provide many mutations in genes whose pathogenic effect must be validated. To functionally validate the impact of gene variations in the disease’s onset and progression, different cell models are commonly used. We review here the use of yeast strains for functional complementation of human genes, dermal skin fibroblasts from patients as an excellent tool to demonstrate the biochemical and genetic mechanisms of these diseases and the development of human-induced pluripotent stem cells (hiPSCs) and iPSC-derived organoids for the study of the pathogenesis and treatment approaches, This work was supported by Junta de Andalucía grants P18-RT-4572, UPO-126247, UPO1265673 and BIO-177, the Instituto de Salud Carlos III FIS grant FIS PI20/00541, the FEDER Funding Pro-gram from the European Union, and CIBERER (U729)-ISCIII, and Spanish Ministry of Science, Innovation and Universities grant RED2018-102576-T, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2–p53 Pathway

  • Barrio, Emilia
  • Vecino, Rebeca
  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Suarez-Pindado, Alberto
  • Bolaños, Juan P.
  • Almeida, Angeles
  • Delgado-Esteban, María
One of the most important mechanisms of preconditioning-mediated neuroprotection is the attenuation of cell apoptosis, inducing brain tolerance after a subsequent injurious ischemia. In this context, the antiapoptotic PI3K/AKT signaling pathway plays a key role by regulating cell differentiation and survival. Active AKT is known to increase the expression of murine double minute-2 (MDM2), an E3-ubiquitin ligase that destabilizes p53 to promote the survival of cancer cells. In neurons, we recently showed that the MDM2–p53 interaction is potentiated by pharmacological preconditioning, based on subtoxic stimulation of NMDA glutamate receptor, which prevents ischemia-induced neuronal apoptosis. However, whether this mechanism contributes to the neuronal tolerance during ischemic preconditioning (IPC) is unknown. Here, we show that IPC induced PI3K-mediated phosphorylation of AKT at Ser473, which in turn phosphorylated MDM2 at Ser166. This phosphorylation triggered the nuclear stabilization of MDM2, leading to p53 destabilization, thus preventing neuronal apoptosis upon an ischemic insult. Inhibition of the PI3K/AKT pathway with wortmannin or by AKT silencing induced the accumulation of cytosolic MDM2, abrogating IPC-induced neuroprotection. Thus, IPC enhances the activation of PI3K/AKT signaling pathway and promotes neuronal tolerance by controlling the MDM2–p53 interaction. Our findings provide a new mechanistic pathway involved in IPC-induced neuroprotection via modulation of AKT signaling, suggesting that AKT is a potential therapeutic target against ischemic injury., This research was funded by the Instituto de Salud Carlos III (PI18/00103 to M.D.-E.; PI18/00285 and RD16/0019/0018 to A.A.; CB16/10/00282 to J.P.B.), MICINN (PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T to J.P.B.; SAF2017-90794-REDT to A.A.), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03; CSI151P20), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.), Fundación Ramón Areces (to A.A.P. and J.P.B.), European Regional Development Fund, and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009 to A.A.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Bates, Georgina
  • Murphy, Michael P.
  • Almeida, Angeles
  • Bolaños, Juan P.
Cells naturally produce mitochondrial reactive oxygen species (mROS), but the in vivo pathophysiological significance has long remained controversial. Within the brain, astrocyte-derived mROS physiologically regulate behaviour and are produced at one order of magnitude faster than in neurons. However, whether neuronal mROS abundance differentially impacts on behaviour is unknown. To address this, we engineered genetically modified mice to down modulate mROS levels in neurons in vivo. Whilst no alterations in motor coordination were observed by down modulating mROS in neurons under healthy conditions, it prevented the motor dis- coordination caused by the pro-oxidant neurotoxin, 3-nitropropionic acid (3-NP). In contrast, abrogation of mROS in astrocytes showed no beneficial effect against the 3-NP insult. These data indicate that the impact of modifying mROS production on mouse behaviour critically depends on the specific cell-type where they are generated., J.P.B. is funded by the Agencia Estatal de Investigación (SAF2016-78114-R, PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), ISCIII (CB16/10/00282), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Bio-medicina 2017 Fundación BBVA and Fundación Ramón Areces. A.A. is unded by the ISCIII (PI18/00265, RD16/0019/0018), AEI (PI18/00265, RD16/0019/0018) and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009). J.P.B. and A.A. are fundedby the grant CSI151P20 from the Junta de Castilla y Leon., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

p38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1

  • Santamans, Ayelén M.
  • Montalvo-Romeral, Valle
  • Mora, Alfonso
  • Lopez, Juan Antonio
  • Gonzalez-Romero, Francisco
  • Jimenez-Blasco, Daniel
  • Rodríguez, Elena
  • Pintor-Chocano, Aránzazu
  • Casanueva-Benítez, Cristina
  • Acín-Pérez, Rebeca
  • Leiva-Vega, Luis
  • Duran, Joan
  • Guinovart, Joan J.
  • Jiménez-Borreguero, Jesús
  • Enríquez, José Antonio
  • Villlalba-Orero, María
  • Bolaños, Juan P.
  • Aspichueta, Patricia
  • Vázquez, Jesús
  • González-Terán, Bárbara
  • Sabio, Guadalupe
During the first weeks of postnatal heart development, cardiomyocytes undergo a major adaptive metabolic shift from glycolytic energy production to fatty acid oxidation. This metabolic change is contemporaneous to the up-regulation and activation of the p38γ and p38δ stress-activated protein kinases in the heart. We demonstrate that p38γ/δ contribute to the early postnatal cardiac metabolic switch through inhibitory phosphorylation of glycogen synthase 1 (GYS1) and glycogen metabolism inactivation. Premature induction of p38γ/δ activation in cardiomyocytes of newborn mice results in an early GYS1 phosphorylation and inhibition of cardiac glycogen production, triggering an early metabolic shift that induces a deficit in cardiomyocyte fuel supply, leading to whole-body metabolic deregulation and maladaptive cardiac pathogenesis. Notably, the adverse effects of forced premature cardiac p38γ/δ activation in neonate mice are prevented by maternal diet supplementation of fatty acids during pregnancy and lactation. These results suggest that diet interventions have a potential for treating human cardiac genetic diseases that affect heart metabolism., G.S. is a YIP EMBO member. B.G.T. was a fellow of the FPI Severo Ochoa CNIC program (SVP-2013-067639) and currently is funded by the AHA-CHF (AHA award number: 818798). V.M.R. is a FPI fellow (BES-2014-069332) and A.M.S. is a fellow of the FPI Severo Ochoa CNIC program (BES-2016-077635). This work was funded by the following grants: to G.S.: funding from the EFSD/Lilly European Diabetes Research Programme Dr Sabio, from Spanish Ministry of Science, Innovation and Universities (MINECO-FEDER SAF2016-79126-R and PID2019-104399RB-I00), Comunidad de Madrid (IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-3733) and Fundación Jesús Serra; to P.A.: Ayudas para apoyar grupos de investigación del sistema Universitario Vasco (IT971-16 to P.A.), MCIU/AEI/FEDER, funding from Spanish Ministry of Science, Innovation and Universities (RTI2018-095134-B-100); Excellence Network Grant from MICIU/AEI (SAF2016-81975-REDT and 2018-PN188) to PA and GS; to J.V.: funding from Spanish Ministry of Science, Innovation and Universities (PGC2018-097019-B-I00), the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria grant PRB3 (PT17/0019/0003- ISCIII-SGEFI / ERDF, ProteoRed), and “la Caixa” Banking Foundation (project code HR17-00247); to J.P.B.: funding from Spanish Ministry of Science, Innovation and Universities (PID2019-105699RB-I00, RED2018‐102576‐T) and Escalera de Excelencia (CLU-2017-03); to J.A.E.: funding from Spanish Ministry of Science, Innovation and Universities MINECO (RED2018-102576-T, RTI2018-099357-B-I00), CIBERFES (CB16/10/00282), and HFSP (RGP0016/2018). RAP (XPC/BBV1602 and MIN/RYC1102). The CNIC is supported by the Ministry of Science, Innovation and Universities and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Bates, Georgina
  • Murphy, Michael P.
  • Almeida, Angeles
Cells naturally produce mitochondrial reactive oxygen species (mROS), but the in vivo pathophysiological significance has long remained controversial. Within the brain, astrocyte-derived mROS physiologically regulate behaviour and are produced at one order of magnitude faster than in neurons. However, whether neuronal mROS abundance differentially impacts on behaviour is unknown. To address this, we engineered genetically modified mice to down modulate mROS levels in neurons in vivo. Whilst no alterations in motor coordination were observed by down modulating mROS in neurons under healthy conditions, it prevented the motor discoordination caused by the pro-oxidant neurotoxin, 3-nitropropionic acid (3-NP). In contrast, abrogation of mROS in astrocytes showed no beneficial effect against the 3-NP insult. These data indicate that the impact of modifying mROS production on mouse behaviour critically depends on the specific cell-type where they are generated., J.P.B. is funded by the Agencia Estatal de Investigación (SAF2016-78114-R, PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), ISCIII (CB16/10/00282), Junta de Castilla y Le ́on (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundaci ́on BBVA and Fundaci ́on Ram ́on Areces. A.A. is funded by the ISCIII (PI18/00265, RD16/0019/0018), AEI (SAF2017-90794-REDT) and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009). J.P.B. and A.A. are funded by the grant CSI151P20 from the Junta de Castilla y Leon.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Opa1 relies on cristae preservation and ATP synthase to curtail reactive oxygen species accumulation in mitochondria

  • Quintana-Cabrera, Ruben
  • Manjarrés-Raza, Israel
  • Vicente-Gutiérrez, Carlos
  • Corrado, Mauro
  • Bolaños, Juan P.
  • Scorrano, Luca
Reactive oxygen species (ROS) are a common product of active mitochondrial respiration carried in mitochondrial cristae, but whether cristae shape influences ROS levels is unclear. Here we report that the mitochondrial fusion and cristae shape protein Opa1 requires mitochondrial ATP synthase oligomers to reduce ROS accumulation. In cells fueled with galactose to force ATP production by mitochondria, cristae are enlarged, ATP synthase oligomers destabilized, and ROS accumulate. Opa1 prevents both cristae remodeling and ROS generation, without impinging on levels of mitochondrial antioxidant defense enzymes that are unaffected by Opa1 overexpression. Genetic and pharmacologic experiments indicate that Opa1 requires ATP synthase oligomerization and activity to reduce ROS levels upon a blockage of the electron transport chain. Our results indicate that the converging effect of Opa1 and mitochondrial ATP synthase on mitochondrial ultrastructure regulate ROS abundance to sustain cell viability., R.Q.-C was supported by an AIRC and a Fondazione Veronesi fellowship and by a H2020 Marie Sklodowska-Curie IEF GA793987. J.P.B. is funded by Agencia Estatal de Investigación (PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018‐102576‐T), Instituto de Salud Carlos III (CB16/10/00282), Escalera de Excelencia CLU-2017-03, Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces. This work was supported by AIRC IG19991, Italian Ministry of Education, University and Research PRIN 2017BF3PXZ, Fondation Leducq TNE15004, Muscular Dystrophy Association (MDA USA) RG 603731 and Cariparo Foundation SIGMI (to L.S.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Astrocyte-neuron metabolic cooperation shapes brain activity

  • Bonvento, Gilles
  • Bolaños, Juan P.
The brain has almost no energy reserve, but its activity coordinates organismal function, a burden that requires precise coupling between neurotransmission and energy metabolism. Deciphering how the brain accomplishes this complex task is crucial to understand central facets of human physiology and disease mechanisms. Each type of neural cell displays a peculiar metabolic signature, forcing the intercellular exchange of metabolites that serve as both energy precursors and paracrine signals. The paradigm of this biological feature is the astrocyte-neuron couple, in which the glycolytic metabolism of astrocytes contrasts with the mitochondrial oxidative activity of neurons. Astrocytes generate abundant mitochondrial reactive oxygen species and shuttle to neurons glycolytically derived metabolites, such as L-lactate and L-serine, which sustain energy needs, conserve redox status, and modulate neurotransmitter-receptor activity. Conversely, early disruption of this metabolic cooperation may contribute to the initiation or progression of several neurological diseases, thus requiring innovative therapies to preserve brain energetics., G.B. received grants from the Centre National de la Recherche Scientifique (CNRS), the Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), Agence Nationale de la Recherche (ANR 2011 MALZ-0003 MetALZ; ANR-18-C816-0008-03 ADORASTrAU), Association France Alzheimer, Fondation de France (Prix Spécial 2012), Fondation Alzheimer, and Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences (NeurATRIS ANR-11-INBS-0011). J.P.B. is funded by the Agencia Estatal de Investigación (PID2019-105699RB-I00 / AEI / 10.13039/501100011033 and RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), Junta de Castilla y León (CSI151P20 and Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, and Fundación Ramón Areces.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ultrasmall manganese ferrites for in vivo catalase mimicking activity and multimodal bioimaging

  • Carregal-Romero, Susana
  • Miguel-Coello, Ana Beatriz
  • Martínez-Parra, Lydia
  • Martí-Mateo, Yolanda
  • Hernansanz-Agustín, Pablo
  • Fernández-Afonso, Yilian
  • Plaza-García, Sandra
  • Gutiérrez, Lucía
  • Muñoz-Hernández, María del Mar
  • Carrillo-Romero, Juliana
  • Piñol-Cancer, Marina
  • Lecante, Pierre
  • Blasco-Iturri, Zuriñe
  • Fadón, Lucía
  • Almansa-García, Ana C.
  • Möller, Marco
  • Otaegui, Dorleta
  • Enríquez, Jose Antonio
  • Groult, Hugo
  • Ruíz-Cabello, Jesús
Manganese ferrite nanoparticles display interesting features in bioimaging and catalytic therapies. They have been recently used in theranostics as contrast agents in magnetic resonance imaging (MRI), and as catalase-mimicking nanozymes for hypoxia alleviation. These promising applications encourage the development of novel synthetic procedures to enhance the bioimaging and catalytic properties of these nanomaterials simultaneously. Herein, a cost-efficient synthetic microwave method is developed to manufacture ultrasmall manganese ferrite nanoparticles as advanced multimodal contrast agents in MRI and positron emission tomography (PET), and improved nanozymes. Such a synthetic method allows doping ferrites with Mn in a wide stoichiometric range (MnxFe3-xO4, 0.1 ≤ x ≤ 2.4), affording a library of nanoparticles with different magnetic relaxivities and catalytic properties. These tuned magnetic properties give rise to either positive or dual-mode MRI contrast agents. On the other hand, higher levels of Mn doping enhance the catalytic efficiency of the resulting nanozymes. Finally, through their intracellular catalase-mimicking activity, these ultrasmall manganese ferrite nanoparticles induce an unprecedented tumor growth inhibition in a breast cancer murine model. All of these results show the robust characteristics of these nanoparticles for nanobiotechnological applications., The authors thank M. Jeannin from Lasie Laboratory (La Rochelle University) for the Raman studies. S.C.R. is supported by the grant PID2019-106139RA-100 funded by MCIN. J.R.-C. is supported by grants from the Ministerio de Economía, Industria y Competitividad (MEIC) (SAF2017-84494-C2-R). J.R.C. received funding from the BBVA Foundation (PR [18]_BIO_IMG_0008) and La Caixa (HR18-00052). Y.F.-A. received funding from the Santander-Universidad Zaragoza Fellowship program. L.G. acknowledges financial support from the Ramón y Cajal program (RYC-2014-15512). CIC biomaGUNE is supported by the Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency (MDM-2017-0720). The authors acknowledge the use of Servicio General de Apoyo a la Investigación-SAI, Universidad de Zaragoza. H.G. is supported by the Ligue contre le Cancer (CD16, CD17) and Région Nouvelle Aquitaine (Projet “Nanovect”). J.A.E. is supported by RTI2018-099357-B-I00, HFSP (RGP0016/2018), CIBERFES16/10/00282 and RED2018-102576-T. The CNIC is supported by the Pro-CNIC Foundation and by the Severo Ochoa of Excellence Program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic Messengers: endocannabinoids

  • Busquets-Garcia, Arnau
  • Bolaños, Juan P.
  • Marsicano, Giovanni
Endocannabinoid signalling is considered one of the most important modulatory systems in a whole organism. Research has yielded great insight on the mechanisms that link endocannabinoids and metabolic functions. Here, we provide a brief overview of the metabolic roles of endocannabinoids in tissue, cellular and subcellular-dependent mechanisms. In general, we point out how the central and peripheral control of body energy metabolism likely represents the main function of type-1 cannabinoid receptors. More specifically, we focus on recent advances underlying mechanisms of endocannabinoid control of cell metabolism through the modulation of the functions of specific organelles. While highlighting a historical summary and summarizing past discoveries, this short review aims at proposing future open questions for a field that does not stop surprising researchers with unexpected and exciting discoveries., We also thank all the members of A.B.-G.’s, J.P.B.’s and G.M.’s labs for useful discussions and for their invaluable support. The work of A.B.-G. is supported by: Agencia Estatal de Investigación-FEDER (RTI2018-093667-A-100); the ERC starting Grant (HighMemory, #948217); the IBRO Return Home Fellowships 2019 and the Ramon y Cajal programme (RYC-2017-21776) funded by MCIN/ AEI/10.13039/501100011033 and FSE). The work of J.P.B. is funded by the Agencia Estatal de Investigación (PID2019-105699RB-I00; PDC2021-121013-I00; RED2018‐102576‐T; MCIN/AEI/10.13039/501100011033 & European Union NextGenerationEU/PRTR), Plan Nacional de Drogas (Ministerio de Sanidad; 2020I028) and Junta de Castilla y León (CS/151P20 and Escalera de Excelencia CLU-2017-03). The work of G.M. is funded by: INSERM, European Research Council (Endofood, ERC–2010–StG–260515 and CannaPreg, ERC-2014-PoC-640923, MiCaBra, ERC-2017-AdG-786467), Fondation pour la Recherche Medicale (FRM, DRM20101220445), the Human Frontiers Science Program, Region Nouvelle Aquitaine, Agence Nationale de la Recherche (ANR, NeuroNutriSens ANR-13-BSV4-0006 and ORUPS ANR-16-CE37-0010-01 and BRAIN ANR-10-LABX-0043).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial sodium/calcium exchanger NCLX regulates glycolysis in astrocytes, impacting on cognitive performance

  • Cabral-Costa, João Victor
  • Vicente-Gutiérrez, Carlos
  • Agulla, Jesús
  • Lapresa, Rebeca
  • Elrod, John W.
  • Almeida, Angeles
  • Bolaños, Juan P.
  • Kowaltowski, Alicia J.
Intracellular Ca2+ concentrations are strictly controlled by plasma membrane transporters, the endoplasmic reticulum, and mitochondria, in which Ca2+ uptake is mediated by the mitochondrial calcium uniporter complex (MCUc), while efflux occurs mainly through the mitochondrial Na+/Ca2+ exchanger (NCLX). RNAseq database repository searches led us to identify the Nclx transcript as highly enriched in astrocytes when compared with neurons. To assess the role of NCLX in mouse primary culture astrocytes, we inhibited its function both pharmacologically or genetically. This resulted in re-shaping of cytosolic Ca2+ signaling and a metabolic shift that increased glycolytic flux and lactate secretion in a Ca2+-dependent manner. Interestingly, in vivo genetic deletion of NCLX in hippocampal astrocytes improved cognitive performance in behavioral tasks, whereas hippocampal neuron-specific deletion of NCLX impaired cognitive performance. These results unveil a role for NCLX as a novel modulator of astrocytic glucose metabolism, impacting on cognition., Agencia Estatal de Investigación, Grant/Award Number: PDC2021- 1 2 1 0 1 3 - I 0 0 , P I D 2 0 19 - 1 0 5 6 9 9 R B - I 0 0 /AEI/10.13039/501100011033 and RED2018-102576-T; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Grant/Award Number: line 001; Fundação de Amparo à Pesquisa do Estado de São Paulo, Grant/Award Number: #2013/07937-8, #2017/14713-0, #2019/22178-2 and #2020/06970-5; Instituto de Salud Carlos III, Grant/Award Number: PI21/00727 and RD21/0006/0005 co-funded by the European Union FED; Junta de Castilla y León, Grant/Award Number: Apoyo Regional a la Competitividad Empresarial, IC, CS/151P20 co-funded by P.O. FEDER and Escalera de Excelencia CLU-2017- 03; Plan Nacional de Drogas, Grant/Award Number: 2020I028, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Brightness and shadows of mitochondrial ROS in the brain

  • Jimenez-Blasco, Daniel
  • Almeida, Angeles
  • Bolaños, Juan P.
Mitochondrial reactive oxygen species (mROS) have been generally considered harmful byproducts wanted to clear when elevated to avoid brain damage. However, the abundance of mROS in astrocytes is very high -about one order of magnitude above that in neurons-, despite they are essential to preserve cell metabolism and animal behavior. Here, we have focused on this apparent ambiguity by discussing (i) the intrinsic mechanisms accounting for the higher production of mROS by the mitochondrial respiratory chain in astrocytes than in neurons, (ii) the specific molecular targets of astrocytic beneficial mROS, and (iii) how decreased astrocytic mROS causes excess neuronal mROS leading to cellular and organismal damage. We hope that this mini-review serves to clarifying the apparent controversy on the beneficial versus deleterious faces of ROS in the brain from molecular to higher-order organismal levels., Authors were supported by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PID2022-138813OB-I00; PDC2021–121013-I00; RED2018–102576-T to JPB; RED2022–134407-T to AA); Plan Nacional de Drogas (2020I028 to JPB); Instituto de Salud Carlos III (CB16/10/00282 to JPB; PI21/00727; PMP22/00084 and RD21/0006/0005 co-funded by the European Union, to AA); Marie Sklodowska-Curie Action HORIZON-MSCA-2021-DN-01 (101072759 to JPB and AAP), and Junta de Castilla y León (CS/151P20 co-funded by P.O. FEDER to AA; Apoyo Regional a la Competitividad Empresarial, ICE 04/18/LE/0017 to JPB, and Escalera de Excelencia CLU-2017-03 to JPB and AA). DJB is a recipient of a Juan de la Cierva-Incorporación contract (IJC2020–044230-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition

  • Morant Ferrando, Brenda
  • Jimenez-Blasco, Daniel
  • Alonso-Batán, Paula
  • Agulla, Jesús
  • Lapresa, Rebeca
  • Garcia-Rodriguez, Dario
  • Yunta-Sanchez, Sara
  • López-Fabuel, Irene
  • Fernández, Emilio
  • Carmeliet, Peter
  • Almeida, Angeles
  • García-Macia, Marina
  • Bolaños, Juan P.
Having direct access to brain vasculature, astrocytes can take up available blood nutrients and metabolize them to fulfil their own energy needs and deliver metabolic intermediates to local synapses. These glial cells should be, therefore, metabolically adaptable to swap different substrates. However, in vitro and in vivo studies consistently show that astrocytes are primarily glycolytic, suggesting glucose is their main metabolic precursor. Notably, transcriptomic data and in vitro studies reveal that mouse astrocytes are capable of mitochondrially oxidizing fatty acids and that they can detoxify excess neuronal-derived fatty acids in disease models. Still, the factual metabolic advantage of fatty acid use by astrocytes and its physiological impact on higher-order cerebral functions remain unknown. Here, we show that knockout of carnitine-palmitoyl transferase-1A (CPT1A)—a key enzyme of mitochondrial fatty acid oxidation—in adult mouse astrocytes causes cognitive impairment. Mechanistically, decreased fatty acid oxidation rewired astrocytic pyruvate metabolism to facilitate electron flux through a super-assembled mitochondrial respiratory chain, resulting in attenuation of reactive oxygen species formation. Thus, astrocytes naturally metabolize fatty acids to preserve the mitochondrial respiratory chain in an energetically inefficient disassembled conformation that secures signalling reactive oxygen species and sustains cognitive performance., We acknowledge the technical assistance of M. Resch, M. Carabias-Carrasco, L. Martin and E. Prieto-Garcia, from the University of Salamanca. This work was funded by the European Regional Development Fund, Agencia Estatal de Investigación (grant nos. PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018‐102576‐T to J.P.B. and SAF2017-90794-REDT to A.A.), Instituto de Salud Carlos III (grant nos. CB16/10/00282 to J.P.B. and PI18/00285 and RD16/0019/0018 to A.A.), Junta de Castilla y León (grant no. CS/151P20) and Escalera de Excelencia (grant no. CLU-2017-03 to J.P.B. and A.A.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

γ-Linolenic acid in maternal milk drives cardiac metabolic maturation

  • Paredes, Ana
  • Justo-Méndez, Raquel
  • Jimenez-Blasco, Daniel
  • Núñez, Vanessa
  • Calero, Irene
  • Villalba-Orero, María
  • Alegre-Martí, Andrea
  • Fischer, Thierry
  • Gradillas, Ana
  • Rodrigues Sant’Anna, Viviane Aparecida
  • Were, Felipe
  • Huang, Zhiqiang
  • Hernansanz-Agustín, Pablo
  • Contreras, Carmen
  • Martínez, Fernando
  • Camafeita, Emilio
  • Vázquez, Jesús
  • Ruiz-Cabello, Jesús
  • Area-Gomez, Estela
  • Sánchez-Cabo, Fátima
  • Treuter, Eckardt
  • Bolaños, Juan P.
  • Estébanez-Perpiñá, Eva
  • Rupérez, Francisco Javier
  • Barbas, Coral
  • Enríquez, José Antonio
  • Ricote, M. Mercedes
Birth presents a metabolic challenge to cardiomyocytes as they reshape fuel preference from glucose to fatty acids for postnatal energy production. This adaptation is triggered in part by post-partum environmental changes, but the molecules orchestrating cardiomyocyte maturation remain unknown. Here we show that this transition is coordinated by maternally supplied γ-linolenic acid (GLA), an 18:3 omega-6 fatty acid enriched in the maternal milk. GLA binds and activates retinoid X receptors (RXRs), ligand-regulated transcription factors that are expressed in cardiomyocytes from embryonic stages. Multifaceted genome-wide analysis revealed that the lack of RXR in embryonic cardiomyocytes caused an aberrant chromatin landscape that prevented the induction of an RXR-dependent gene expression signature controlling mitochondrial fatty acid homeostasis. The ensuing defective metabolic transition featured blunted mitochondrial lipid-derived energy production and enhanced glucose consumption, leading to perinatal cardiac dysfunction and death. Finally, GLA supplementation induced RXR-dependent expression of the mitochondrial fatty acid homeostasis signature in cardiomyocytes, both in vitro and in vivo. Thus, our study identifies the GLA–RXR axis as a key transcriptional regulatory mechanism underlying the maternal control of perinatal cardiac metabolism., The authors thank the members of the M.R. and J.A.E laboratories, A. Hidalgo and M. Torres for extensive discussions of the paper; G. Sabio, N. Rochel and D. Metzger for mice and reagents; CNIC and CRG Genomics Units for sequencing; S. Bartlett for editorial assistance; and A.V. Alonso, L. Flores, R. Baeza, R. Santos-Clemente, C. Gifford and N. Spann for technical assistance. J.P.B. is funded by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PDC2021-121013-I00, RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), and Junta de Castilla y León (Apoyo Regional a la Competitividad Empresarial, ICE 04/18/LE/0017 and Escalera de Excelencia CLU-2017-03). D.J.-B. And P.H.A. are recipients of a Juan de la Cierva-Incorporación contracts (IJC2020-044230-I and IJC2020-042679-I, respectively). F.J.R. is funded by the Ministerio de Ciencia e Innovación (MCIN) and European Regional Development Fund FEDER (PID2021- 122490NB-I00). V.A.R.S. received funding from Airbus Defense and Space through the CLX-2 programme in partnership with Comando da Aeronautica (COMAER) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES). E.T. received funding from the Swedish Research Council (2020-01150), the Swedish Cancer Society (211582), and the Novo Nordisk Foundation (NNF20OC0063672). J.A.E. was supported by RTI2018-099357-B-I00, MCIU/AEI/ ERDF/UE; RTI2018-099357-B-I00 MCIU/AEI; PID2021-1279880B-100 MCIN/AEI/ 10.13039/501100011033/ERDF,UE; CB16/10/00282 CIBERFES and 17CVD04 Foundation Leducq. This work was supported by grants to M.R.: SAF2017-90604-REDT-NurCaMeIn MINECO/AEI; RTI2018-095928-BI00, MCIU/AEI/ ERDF/UE; PID2021-122552OB-I00 MCIN/AEI/ 10.13039/501100011033/ERDF,UE; 201605-32 Fundació La Marató de TV3; and S2017/BMD- 3684 Comunidad de Madrid/ESF/EU, S2022/BMD-7227 Comunidad de Madrid; and an MINECO fellowship to A.P. (BES-2016-076632/AEI/ESF) and to R.J.-M. (PRE2019-087462). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/ AEI/ 10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A special issue in Essays in Biochemistry on astrocytes-more than a neuronal support network

  • Bolaños, Juan P.
Astrocytes are a type of non-neuronal, glial cells, anatomically placed in the intersection between the brain blood vessels and other neural cells-including neurons. Such a strategic situation confers these cells a unique opportunity to sense circulating molecules and adapt according to different organismal conditions. By acting as sentinel cells, astrocytes thus co-ordinate gene expression profiles, immune responses, signal transduction pathways, and metabolic programs that play essential roles in the formation of brain circuits to modulate neurotransmission and higher-order organismal functions., This work was funded by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (grant numbers 10.13039/501100011033, PID2019-105699RB-I00, PDC2021-121013-I00, RED2018‐102576‐T); Instituto de Salud Carlos III (grant number CB16/10/00282); and Junta de Castilla y León (grant numbers CS/151P20, Escalera de Excelencia CLU-2017-03)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus

  • Borrás, Consuelo
  • Abdelaziz, Kheira M.
  • Díaz, Ana
  • Gambini,Juan
  • Jové Font, Mariona
  • López-Grueso, Raul
  • Mas-Bargues, Cristina
  • Monleón, Daniel
  • Pamplona Gras, Reinald
  • Viña Ribes, José
Soya consumption can decrease oxidative stress in animal models. Moreover, phytoestrogens such as genistein, present in soya, can mimic some of the beneficial effects of estrogens and are devoid of significant side effects, such as cancer. In this study, we have performed a controlled lifelong study with male OF1 mice that consumed either a soya-free diet or a soya-rich diet. We show that, although we found an increase in the expression and activity of antioxidant enzymes in soya-consuming mice, it did not increase lifespan. We reasoned that the soya diet could not increase lifespan in a very healthy population, but perhaps it could extend health span in stressed animals such as type 2 diabetic Goto Kakizaki (GK) rats. Indeed, this was the case: we found that male GK rats consuming a soya-rich diet developed the disease at a lower rate and, therefore, lived longer than soya-free dietconsuming rats., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RBI00/AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería, de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N◦ 696295 of the EU Horizon 2020 Research and Innovation Programme) to J.V. and PID2020-113839RB-I00 of the Ministry of Science and Innovation, PCIN-2017-117 of the Ministry of Economy and Competitiveness, the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to C.B. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mitochondrial dynamics maintain muscle stem cell regenerative competence throughout adult life by regulating metabolism and mitophagy

  • Hong, Xiaotong
  • Isern, Joan
  • Campanario, Silvia
  • Perdiguero, Eusebio, 1968-
  • Ramírez Pardo, Ignacio
  • Segalés Dalmau, Jessica
  • Hernansanz-Agustín, Pablo
  • Curtabbi, Andrea
  • Deryagin, Oleg
  • Pollán, Angela
  • González-Reyes, José A.
  • Villalba, José M.
  • Sandri, Marco
  • Serrano Sánchez, Antonio L.
  • Enríquez, José Antonio
  • Muñoz Cánoves, Pura, 1962-
Skeletal muscle regeneration depends on the correct expansion of resident quiescent stem cells (satellite cells), a process that becomes less efficient with aging. Here, we show that mitochondrial dynamics are essential for the successful regenerative capacity of satellite cells. The loss of mitochondrial fission in satellite cells-due to aging or genetic impairment-deregulates the mitochondrial electron transport chain (ETC), leading to inefficient oxidative phosphorylation (OXPHOS) metabolism and mitophagy and increased oxidative stress. This state results in muscle regenerative failure, which is caused by the reduced proliferation and functional loss of satellite cells. Regenerative functions can be restored in fission-impaired or aged satellite cells by the re-establishment of mitochondrial dynamics (by activating fission or preventing fusion), OXPHOS, or mitophagy. Thus, mitochondrial shape and physical networking controls stem cell regenerative functions by regulating metabolism and proteostasis. As mitochondrial fission occurs less frequently in the satellite cells in older humans, our findings have implications for regeneration therapies in sarcopenia., Work in the PMC laboratory was supported by Spanish Ministerio de Ciencia e Innovación ( RTI2018-096068 to P.M.-C. and E.P), ERC - 2016-AdG-741966 , LaCaixa - HEALTH-HR17-00040 , MDA , UPGRADE-H2020-825825 , AFM-Telethon , DPP-Spain , Fundació La Marató TV3-80/19-202021 to P.M.-C; Fundació La Marató TV3-137/38-202033 to A.L.S.; partly supported by Milky Way Research Foundation (MWRF) to P.M.-C; Severo Ochoa Program for Centers of Excellence to CNIC ( SEV-2015-0505 ) and Maria de Maeztu Program for Units of Excellence to UPF ( MDM-2014-0370 ). Work in the JAE laboratory was supported by Ministerio de Ciencia e Innovacion ( RTI2018-099357-B-I00 , RED2018-102576-T ), Human Frontier Science Program HFSP ( RGP0016/2018 ), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimento Saludable ( CIBERFES16/10/00282 ), and Leduq Foundation award ( REDOX-17CVD04 ). Work in JMV laboratory was supported by the Spanish Ministerio de Ciencia e Innovación ( RTI2018-100695-B-I00 ), Spanish Junta de Andalucía ( P18-RT-4264 , 1263735-R and BIO-276 ), the FEDER Funding Program from the European Union , and Universidad de Córdoba . The authors are indebted to the personnel from the Servicio Centralizado de Apoyo a la Investigación (SCAI; University of Córdoba) for technical support with the transmission electron microscope. Work in MS laboratory was funded by the Italian Assoc. for Cancer Research ( AIRC IG-D17388 and ID23257 ) and ASI (MARS-PRE, project DC-VUM-2017-006). X.H., S.C., I.R.-P, and A.C were supported by Severo Ochoa PFI , PI , FPI , and H2020 Marie Skłodowska-Curie Actions predoctoral fellowships, respectively. P.H.-A was supported by Juan de la Cierva-Incorporación fellowship.